Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2025-12-24 @ 11:34 PM
NCT ID:
NCT02592356
Eligibility Criteria:
Inclusion Criteria:
* Age \>/= 18 years
* Initiating cabozantinib for progressive DTC, MTC, malignant PH or PGs or lenvatinib for progressive DTC or MTC as determined by patient's endocrinologist
* ECOG performance status 0-2
* Able to communicate in English or Spanish
* Able to provide informed consent
Exclusion Criteria:
* Active participation in any weight reduction program including use of drugs used for weight loss
* Inability to ambulate without assistance (e.g. cane, walker)
* Multiple Endocrine Neoplasia (MEN) 2B (due to differences in body habitus)
* Patients unwilling or unable to comply with the protocol.
* Use of chronic (\>3 months consecutively) non-physiological (15 mg/m² hydrocortisone equivalent) doses of glucocorticoids
* Non-English speaking PH and PG patients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02592356
Study Brief:
Protocol Section:
NCT02592356